
Keywords: Acute kidney injury (AKI); colistin; colistin methanesulfonate; polymyxin E; continuous renal replacement therapies (CRRTs); renal toxicity; nephrotoxicity; chronic kidney disease (CKD); critical illness; dialysis; hemofiltration; kidney function; colisti